CIMP-negative Caco-2 cells [56] displayed very low methylation rates (0.4%–2.7%) over all treatments, suggesting that regulation of MLH1 expression in non-CIMP cancer types rather lies beyond DNA methylation. The gene discussed is MLH1; the disease is cancer.